Status:
COMPLETED
Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic
Lead Sponsor:
University Hospital, Ghent
Conditions:
Coronavirus
COVID
Eligibility:
All Genders
18-47 years
Brief Summary
The COVID-19 pandemic brought new challenges to our nationwide healthcare system, with rapid escalation of the number of affected individuals over a handful of weeks. From March 13, a first set of mea...
Eligibility Criteria
Inclusion
- patients that did not start a fertility treatment yet ("intake group") OR;
- patients for which a treatment plan was made, but treatment was postponed ("before treatment") OR;
- patients who were undergoing a non-inf treatment cycle (ovulation-induction (OI), intra-uterine insemination (IUI)) and whose cycle was cancelled after starting the treatment cycle ("non-ivf treatment group") OR;
- patients who were undergoing a cryo cycle and whose cycle was cancelled after starting the treatment cycle ("cryo treatment group") OR;
- patients who were undergoing an IVF treatment cycle and for whom fresh embryo transfer was cancelled (freeze-all group).
Exclusion
- Language other than Dutch
Key Trial Info
Start Date :
May 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 18 2020
Estimated Enrollment :
389 Patients enrolled
Trial Details
Trial ID
NCT04396210
Start Date
May 14 2020
End Date
June 18 2020
Last Update
November 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital
Ghent, Belgium, 9000